Morgan Stanley on Thursday upgraded Swiss dermatology company Galderma (GALD.SW) to overweight from equal weight and raised its price target to 210 francs from 160 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target
Humana (HUM) has an average rating of hold and mean price target of $350.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $365.15, Change: $-23.56, Percent Change: -6.06%